logo
episode-header-image
Aug 2021
56m 34s

Jeff Hammerbacher — From data science to...

Lukas Biewald
About this episode

Jeff talks about building Facebook's early data team, founding Cloudera, and transitioning into biomedicine with Hammer Lab and Related Sciences.

(Read more: http://wandb.me/gd-jeff-hammerbacher)

---

Jeff Hammerbacher is a scientist, software developer, entrepreneur, and investor. Jeff's current work focuses on drug discovery at Related Sciences, a biotech venture creation firm that he co-founded in 2020.

Prior to his work at Related Sciences, Jeff was the Principal Investigator of Hammer Lab, a founder and the Chief Scientist of Cloudera, an Entrepreneur-in-Residence at Accel, and the manager of the Data team at Facebook.

---

Follow Gradient Dissent on Twitter: https://twitter.com/weights_biases

---

0:00 Sneak peek, intro

1:13 The start of Facebook's data science team

6:53 Facebook's early tech stack

14:20 Early growth strategies at Facebook

17:37 The origin story of Cloudera

24:51 Cloudera's success, in retrospect

31:05 Jeff's transition into biomedicine

38:38 Immune checkpoint blockade in cancer therapy

48:55 Data and techniques for biomedicine

53:00 Why Jeff created Related Sciences

56:32 Outro

Up next
Jul 8
How DeepL Built a Translation Powerhouse with AI with CEO Jarek Kutylowski
In this episode of Gradient Dissent, Lukas Biewald talks with Jarek Kutylowski, CEO and founder of DeepL, an AI-powered translation company. Jarek shares DeepL’s journey from launching neural machine translation in 2017 to building custom data centers and how small teams can not ... Show More
42m 42s
Jun 10
GitHub CEO Thomas Dohmke on Copilot and the Future of Software Development
In this episode of Gradient Dissent, Lukas Biewald sits down with Thomas Dohmke, CEO of GitHub, to talk about the future of software engineering in the age of AI. They discuss how GitHub Copilot was built, why agents are reshaping developer workflows, and what it takes to make to ... Show More
1h 9m
May 20
From Pharma to AGI Hype, and Developing AI in Finance: Martin Shkreli’s Journey
In this episode of Gradient Dissent, Lukas Biewald talks with Martin Shkreli — the infamous "pharma bro" turned founder — about his path from hedge fund manager and pharma CEO to convicted felon and now software entrepreneur. Shkreli shares his side of the drug pricing controvers ... Show More
1h 30m
Recommended Episodes
Mar 2024
Biotech Special: Computational Drug Discovery with Patrick Finneran
Proteins are nanomachines inside cells and perform the incredible array of tasks required for cells to function. They are composed of a chain of hundreds to thousands of amino acid “building blocks”. Peptides are similar to proteins, but have only about 3 to 30 amino acids. Their ... Show More
43m 22s
Mar 2024
Biotech Special: Scientific Computing Pipelines with Evan Floden
NextFlow is a tool for managing scientific computation workflows. It’s increasingly popular for bioinformatics, computational biology, and other life science applications. Evan Floden is the Co-Founder and CEO of Seqera Labs which develops NextFlow. He joins the show today to tal ... Show More
41m 35s
Apr 2022
1955: Quanterix (NASDAQ: QTRX) Biomarker Detection Technology
Kevin Hrusovsky, CEO of Quanterix and the Powering Precision Health Summit founder, joins me on the Tech Talks Daily Podcast. Kevin has more than 25 years of experience leading life sciences and biotechnology companies and believes that accelerating precision medicine is the key ... Show More
35m 59s
Aug 2021
Discovery, Translation, and the State of Bio Today
On this episode, we are taking a pulse-check on the state of the intersection between biology, healthcare, and technology with two scientists that sit at another intersection, that of academia and industry: Alexander Marson and Patrick Hsu, who are professors at UC San Francisco ... Show More
33m 5s
Mar 2020
What exactly is "data science" these days? (Practical AI #80)
Matt Brems from General Assembly joins us to explain what “data science” actually means these days and how that has changed over time. He also gives us some insight into how people are going about data science education, how AI fits into the data science workflow, and how to diff ... Show More
48m 40s
Feb 2024
Biotech Special: AI Protein Engineering with Eddie Abrams
Antibodies are a type of protein molecule produced by the immune system. They recognize and attach to other molecules with remarkable precision. Typically antibodies target foreign objects, like viruses, to mark them for destruction. However, they can also be engineered to treat ... Show More
45m 1s